| Cat.No. | Name | Information |
|---|---|---|
| M2225 | Thalidomide | Thalidomide is a sedative and immunomodulator used to study the symptoms of many cancers, it has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties. Thalidomide inhibits cereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ∼250 nM. |
| M43846 | 3-(4-(4-(hydroxymethyl)piperidin-1-yl)phenyl)piperidine-2,6-dione | 3-(4-(4-(hydroxymethyl)piperidin-1-yl)phenyl)piperidine-2,6-dione |
| M43845 | 3-[4-[3,3-Difluoro-4-(methylamino)-1-piperidinyl]phenyl]-2,6-piperidinedione | 3-[4-[3,3-Difluoro-4-(methylamino)-1-piperidinyl]phenyl]-2,6-piperidinedione |
| M43424 | CRBN ligand-9 | CRBN ligand-9 is a CRBN ligand (Ki: 8.9 μM). |
| M43423 | CC-3060 | CC-3060 is a Cereblon modulator that promotes ZBTB16 degradation. |
| M43422 | DCAF1 binder 1 | DCAF1 binder 1 is a selective for the CRL4 DCAF1 E3 ligase complex. |
| M43421 | E3 ubiquitin ligase binder-1 | E3 ubiquitin ligase binder-1 is a potent E3 ubiquitin ligase binder. |
| M43420 | OICR-8268 | OICR-8268 is a reversible DCAF1 ligand that binds to the DCAF1 WDR domain with a Kd of 38 nM. |
| M43419 | Pomalidomide-C11-NH2 | Pomalidomide-C11-NH2 is the Pomalidomide-based cereblon (CRBN) ligand used in the recruitment of CRBN protein. |
| M43418 | Thalidomide-5-propargyl | Thalidomide-5-propargyl is a propargyl-modified Thalidomide, that acts as a Cereblon ligand to recruit CRBN proteins. |
| M43417 | AR antagonist 1 hydrochloride | AR antagonist 1 hydrochloride is a potent androgen receptor (AR) antagonist and binds to E3 ligase ligands with weak binding affinities to VHL protein in the synthesis of PROTAC ARD-266. |
| M40930 | CC-91633 | CC-91633 is a Cereblon (CRBN) modulator for studies related to acute myeloid leukemia and myelodysplastic syndromes. |
| M40929 | CC-11006 | CC-11006 is a Cereblon (CRBN) modulator for studies related to amyotrophic lateral sclerosis and myelodysplastic syndromes. |
| M30423 | Thalidomide-5-OH | Thalidomide-5-OH is the Thalidomide-based cereblon ligand used in the recruitment of CRBN protein. Thalidomide-5-OH can be connected to the ligand for protein by a linker to form PROTACs. |
| M29578 | SLF TFA | SLF TFA is a synthetic ligand for FK506-binding protein (FKBP) with an affinity of 3.1 μM for FKBP51 and an IC50 of 2.6 μM for FKBP12. SLF TFA can be used in the synthesis of PROTAC. |
| M29443 | TD-106 | TD-106 is a cereblon (CRBN) modulator, which can be used for targeted protein degradation. BRD4 PROTACs with TD-106 induce BRD4 degradation. |
| M29055 | SLF | SLF is a synthetic ligand for FK506-binding protein (FKBP) with an affinity of 3.1 μM for FKBP51 and an IC50 of 2.6 μM for FKBP12. SLF can be used in the synthesis of PROTAC. |
| M28465 | VL285 | VL285 is a potent VHL ligand with an IC50 of 0.34 μM. |
| M21353 | Golcadomide | Golcadomide (CC-99282) is a potent and orally active CRBN E3 ligase modulator (CELMoD).CC-99282 co-induces effective and targeted degradation of Ikaros and Aiolos with CRBN.CC-99282 can be used in studies of non-Hodgkin's lymphoma. |
| M21151 | ZXH-1-161 | ZXH-1-161 is a potent cereblon (CRBN) regulator with an IC50 of 39 μM in wild-type MM1.S cells. ZXH-1-161 has selective degradation activity against GSPT1. ZXH-1-161 can be used in the study of multiple myeloma. |
| M14867 | VH032 | VH032 is a VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. VH032 is a VHL/HIF-1α interaction inhibitor with a Kd value of 185 nM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
